Patents by Inventor James Edward Brehove

James Edward Brehove has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7288533
    Abstract: A topical applications is used to treat and prevent the spread of nail infections or onychomycosis caused by bacteria, fungi and other pathogens. The topical application has a composition that comprises, as an active ingredient, at least one species selected from the group consisting of 2,2?-(alkyldioxy) bis-(alkyl-1,3,2-dioxaborinane) and 2,2?-oxybis(alkyl-1,3,2-dioxaborinane). More specifically, the composition comprises, as an active ingredient, at least one member selected from the group consisting of 2,2?-(1-methyltrimethylene dioxy) bis-(4-methyl-1,3,2-dioxaborinane) and 2,2?-oxybis (4,4,6-trimethyl-1,3,2-dioxaborinane).
    Type: Grant
    Filed: December 29, 2004
    Date of Patent: October 30, 2007
    Inventor: James Edward Brehove
  • Patent number: 6878365
    Abstract: A topical applications is used to treat and prevent the spread of nail infections or onychomycosis caused by bacteria, fungi and other pathogens. The topical application has a composition that comprises, as an active ingredient, at least one species selected from the group consisting of 2,2?-(alkyldioxy)bis-(alkyl-1,3,2-dioxaborinane) and 2,2?-oxybis(alkyl-1,3,2-dioxaborinane). More specifically, the composition comprises, as an active ingredient, at least one member selected from the group consisting of 2,2?-(1-methyltrimethylenedioxy)bis-(4-methyl-1,3,2-dioxaborinane) and 2,2?-oxybis(4,4,6-trimethyl-1,3,2-dioxaborinane).
    Type: Grant
    Filed: February 15, 2002
    Date of Patent: April 12, 2005
    Inventor: James Edward Brehove
  • Publication number: 20020165121
    Abstract: A topical applications is used to treat and prevent the spread of nail infections or onychomycosis caused by bacteria, fungi and other pathogens. The topical application has a composition that comprises, as an active ingredient, at least one species selected from the group consisting of 2,2′-(alkyldioxy) bis-(alkyl-1,3,2-dioxaborinane) and 2,2′-oxybis(alkyl-1,3,2-dioxaborinane). More specifically, the composition comprises, as an active ingredient, at least one member selected from the group consisting of 2,2′-(1-methyltrimethylene dioxy) bis-(4-methyl-1, 3, 2-dioxaborinane) and 2,2′-oxybis (4, 4, 6-trimethyl-1, 3, 2-dioxaborinane).
    Type: Application
    Filed: February 15, 2002
    Publication date: November 7, 2002
    Inventor: James Edward Brehove